Tumor necrosis factor receptor superfamily, member 1B haplotypes increase or decrease the risk of inflammatory bowel diseases in a New Zealand caucasian population

Gastroenterology Research and Practice

Volumn , Issue , 2009, Pages

  Ferguson, Lynnette R ^a,b   Han, Dug Yeo ^a,b   Huebner, Claudia ^a,b   Petermann, Ivonne ^a,b   Barclay, Murray L ^c,d   Gearry, Richard B ^c,d   McCulloch, Alan ^b,e   Demmers, Pieter S ^b,f  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b Nutrigenomics New Zealand   (New Zealand)

^c CHRISTCHURCH HOSPITAL   (New Zealand)

^d UNIVERSITY OF OTAGO   (New Zealand)

^e THE NEW ZEALAND INSTITUTE FOR PLANT AND FOOD RESEARCH LIMITED   (New Zealand)

^f INVERMAY AGRICULTURAL CENTRE   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 1B; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CAUCASIAN; CHILD; COLITIS; CONTROLLED STUDY; DNA DETERMINATION; ENTERITIS; FEMALE; GENOTYPE; HAPLOTYPE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEW ZEALAND; NEWBORN; POPULATION GENETICS; POPULATION RESEARCH; PRESCHOOL CHILD; RISK ASSESSMENT; SCHOOL CHILD; SCREENING; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING HABIT;

EID: 76349112458     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2009/591704     Document Type: Article

References (32)

1. Ferguson L. R., Shelling A. N., Browning B. L., Huebner C., Petermann I., Genes, diet and inflammatory bowel disease Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2007 622 1-2 70 83 (Pubitemid 47214578)
2. Tsironi E., Feakins R. M., Roberts C. S., Rampton D. S., Phil D., Incidence of inflammatory bowel disease is rising and abdominal tuberculosis is falling in Bangladeshis in East London, United Kingdom The American Journal of Gastroenterology 2004 99 9 1749 1755
3. Schreiber S., Rosenstiel P., Albrecht M., Hampe J., Krawczak M., Genetics of Crohn disease, an archetypal inflammatory barrier disease Nature Reviews Genetics 2005 6 5 376 388 (Pubitemid 40577181)
4. Barrett J. C., Hansoul S., Nicolae D. L., Genome-wide association defines more than 30 distinct susceptibility loci for Crohns disease Nature Genetics 2008 40 8 955 962
5. Gearry R. B., Richardson A., Frampton C. M. A., High incidence of Crohns disease in Canterbury, New Zealand: results of an epidemiologic study Inflammatory Bowel Diseases 2006 12 10 936 943
6. Browning B. L., Huebner C., Petermann I., Association of DLG5 variants with inflammatory bowel disease in the New Zealand Caucasian population and meta-analysis of the DLG5 R30Q variant Inflammatory Bowel Diseases 2007 13 9 1069 1076
7. Browning B. L., Huebner C., Petermann I., Has toll-like receptor 4 been prematurely dismissed as an inflammatory bowel disease gene? Association study combined with meta-analysis shows strong evidence for association The American Journal of Gastroenterology 2007 102 11 2504 2512
8. Ferguson L. R., Browning B. L., Huebner C., Single nucleotide polymorphisms in human Paneth cell defensin A5 may confer susceptibility to inflammatory bowel disease in a New Zealand Caucasian population Digestive and Liver Disease 2008 40 9 723 730
9. Ferguson L. R., Huebner C., Petermann I., Single nucleotide polymorphism in the tumor necrosis factor-alpha gene affects inflammatory bowel diseases risk World Journal of Gastroenterology 2008 14 29 4652 4661
10. Roberts R. L., Gearry R. B., Hollis-Moffatt J. E., IL23R R381Q and ATG16L1 T300A are strongly associated with Crohns disease in a study of New Zealand Caucasians with inflammatory bowel disease The American Journal of Gastroenterology 2007 102 12 2754 2761
11. Roberts R. L., Hollis-Moffatt J. E., Gearry R. B., Kennedy M. A., Barclay M. L., Merriman T. R., Confirmation of association of IRGM and NCF4 with ileal Crohns disease in a population-based cohort Genes Immunity 2008 9 6 561 565
12. Gearry R. B., Roberts R. L., Burt M. J., Effect of inflammatory bowel disease classification changes on NOD2 genotype-phenotype associations in a population-based cohort Inflammatory Bowel Diseases 2007 13 10 1220 1227
13. Ozeki T., Furuya Y., Nagano C., Analysis of linkage between lymphotoxin haplotype and polymorphisms in 5′ -flanking region of tumor necrosis factor gene associated with efficacy of infliximab for Crohns disease patients Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2006 602 1-2 170 174
14. Beltinger C. P., White P. S., Maris J. M., Physical mapping and genomic structure of the human TNFR2 gene Genomics 1996 35 1 94 100
15. Aggarwal B. B., Signalling pathways of the TNF superfamily: a double-edged sword Nature Reviews Immunology 2003 3 9 745 756
16. Baker E., Chen L. Z., Smith C. A., Callen D. F., Goodwin R., Sutherland G. R., Chromosomal location of the human tumor necrosis factor receptor genes Cytogenetics and Cell Genetics 1991 57 2-3 117 118
17. Kemper O., Derr J., Cherif D., Engelmann H., Wallach D., Berger R., The gene for the type II (p75) tumor necrosis factor receptor (TNF-RII) is localized on band 1p36.2-p36.3 Human Genetics 1991 87 5 623 624
18. Chan F. K.-M., Chun H. J., Zheng L., Siegel R. M., Bui K. L., Lenardo M. J., A domain in TNF receptors that mediates ligand-independent receptor assembty and signaling Science 2000 288 5475 2351 2354
19. Cho J. H., Nicolae D. L., Gold L. H., Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1 Proceedings of the National Academy of Sciences of the United States of America 1998 95 13 7502 7507
20. Dieud P., Petit E., Cailleau-Moindrault S., Association between tumor necrosis factor receptor II and familial, but not sporadic, rheumatoid arthritis: evidence for genetic heterogeneity Arthritis Rheumatism 2002 46 8 2039 2044
21. Komata T., Tsuchiya N., Matsushita M., Hagiwara K., Tokunaga K., Association of tumor necrosis factor receptor 2 (TNFR2) polymorphism with susceptibility to systemic lupus erythematosus Tissue Antigens 1999 53 6 527 533
22. Sashio H., Tamura K., Ito R., Polymorphisms of the TNF gene and the TNF receptor superfamily member 1B gene are associated with susceptibility to ulcerative colitis and Crohns disease, respectively Immunogenetics 2002 53 12 1020 1027
23. Waschke K. A., Villani A.-C., Vermeire S., Tumor necrosis factor receptor gene polymorphisms in Crohns disease: association with clinical phenotypes The American Journal of Gastroenterology 2005 100 5 1126 1133
24. Barton A., John S., Ollier W. E. R., Silman A., Worthington J., Association between rheumatoid arthritis and polymorphism of tumor necrosis factor receptor II, but not tumor necrosis factor receptor I, in Caucasians Arthritis Rheumatism 2001 44 1 61 65
25. Tarrant K. M., Barclay M. L., Frampton C. M. A., Gearry R. B., Perianal disease predicts changes in Crohns disease phenotyperesults of a population-based study of inflammatory bowel disease phenotype The American Journal of Gastroenterology 2008 103 12 3082 3093
26. Silverberg M. S., Satsangi J., Ahmad T., Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology Canadian Journal of Gastroenterology 2005 19 supplement A 5 36
27. Burt M. J., George P. M., Upton J. D., The significance of haemochromatosis gene mutations in the general population: implications for screening Gut 1998 43 6 830 836
28. Ihaka R., Gentleman R., R: a language for data analysis and graphics Journal of Computational and Graphical Statistics 1996 5 3 299 314
29. Schall T. J., Lewis M., Koller K. J., Molecular cloning and expression of a receptor for human tumor necrosis factor Cell 1990 61 2 631 370 (Pubitemid 20149367)
30. Morita C., Horiuchi T., Tsukamoto H., Association of tumor necrosis factor receptor type II polymorphism 196R with systemic lupus erythematosus in the Japanese molecular and functional analysis Arthritis Rheumatism 2001 44 12 2819 2827
31. Kawasaki A., Tsuchiya N., Hagiwara K., Takazoe M., Tokunaga K., Independent contribution of HLA-DRB1 and TNF promoter polymorphisms to the susceptibility to Crohns disease Genes Immunity 2000 1 6 351 357
32. Matsukura H., Ikeda S., Yoshimura N., Takazoe M., Muramatsu M., Genetic polymorphisms of tumour necrosis factor receptor superfamily 1A and 1B affect responses to infliximab in Japanese patients with Crohns disease Alimentary Pharmacology Therapeutics 2008 27 9 765 770